de Vicente, J.C.; RodrĂguez-Santamarta, T.; Rodrigo, J.P.; Allonca, E.; Vallina, A.; Singhania, A.; Donate-PĂ©rez del Molino, P.; GarcĂa-Pedrero, J.M.
The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders. J. Clin. Med. 2019, 8, 1376.
https://doi.org/10.3390/jcm8091376
AMA Style
de Vicente JC, RodrĂguez-Santamarta T, Rodrigo JP, Allonca E, Vallina A, Singhania A, Donate-PĂ©rez del Molino P, GarcĂa-Pedrero JM.
The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders. Journal of Clinical Medicine. 2019; 8(9):1376.
https://doi.org/10.3390/jcm8091376
Chicago/Turabian Style
de Vicente, Juan C., Tania RodrĂguez-Santamarta, Juan P. Rodrigo, Eva Allonca, Aitana Vallina, Anusha Singhania, Paula Donate-PĂ©rez del Molino, and Juana M. GarcĂa-Pedrero.
2019. "The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders" Journal of Clinical Medicine 8, no. 9: 1376.
https://doi.org/10.3390/jcm8091376
APA Style
de Vicente, J. C., RodrĂguez-Santamarta, T., Rodrigo, J. P., Allonca, E., Vallina, A., Singhania, A., Donate-PĂ©rez del Molino, P., & GarcĂa-Pedrero, J. M.
(2019). The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders. Journal of Clinical Medicine, 8(9), 1376.
https://doi.org/10.3390/jcm8091376